E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.

  • Law Blogs

Become a Fan

« Dr. Craig Venter Creates First Cell Controlled Entirely by Synthetic DNA | Main | Biotech/Pharma Docket »

June 02, 2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451ca1469e20133efba141d970b

Listed below are links to weblogs that reference Biotech/Pharma Issuances on the Rise:

Comments

Could you provide a key so that I can understand what is meant by the red line and the blue bars? I suspect that the red line represents published applications since none were published in 2000, but would like confirmation. Thanks!

Lisa:

I added a paragraph below the graph that provides an explanation as to what the blue bars and red line represent and how the data was obtained. In brief, your suspicion was correct. Thank you for the comment.

Don

The comments to this entry are closed.

September 2014

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30